Photo of Amy Pritchard Williams

Amy Pritchard Williams

Subscribe to Amy Pritchard Williams's Posts

Amy has deep and wide-ranging experience in representing financial institutions in government enforcement matters, qui tam False Claims Act cases, consumer class actions and bankruptcy proceedings. She is adept in defending and providing pragmatic advice for the successful resolution of complex, multifaceted matters.

Contact:Read more about Amy Pritchard Williams

Summary

  • The False Claims Act (FCA) qui tam provision allows private citizens (relators) to sue on the government’s behalf for FCA violations and receive a portion of any settlement or award.
  • The FCA qui tam provision has evolved since its inception, and recent U.S. Supreme Court cases signal a move to rein in the power of relators.
  • Funding sources, claim truthfulness, and companies’ subjective understanding will be critical issues in FCA enforcement efforts against diversity, equity, and inclusion (DEI) programs.
  • The current Court hasn’t ruled on the constitutionality of the FCA qui tam provision because no case before it directly raised the issue, but it may soon have the chance.

2025 is already shaping up to be an active year for False Claims Act (FCA) litigation. With the recent announcements of executive orders that may expand the FCA as an enforcement tool, as discussed in a recent Troutman Pepper Locke client alert, everyone is keeping a close eye on what is next. In the past few weeks, the U.S. Supreme Court has gotten in on the FCA action.

The U.S. Department of Justice (DOJ) and 18 state attorneys general (AG) announced a settlement with Boston-based QOL Medical, LLC (QOL) and its CEO, Frederick Cooper, to resolve allegations that the company provided unlawful kickbacks to health care providers. Under the terms of the settlement, QOL and Cooper agreed to pay $47 million to resolve allegations that QOL manipulated health care providers into prescribing a drug called Sucraid — an FDA-approved therapy for a rare genetic disorder, Congenital Sucrase-Isomaltase Deficiency (CSID). Regulators alleged that QOL and Cooper violated the Anti-Kickback Statute and federal and state False Claims Acts.

In the fourth episode of our 12 Days of Regulatory Insights podcast series, Dan Waltz is joined by colleague Amy Williams, a partner at Troutman Pepper, and Allison O’Neil, co-chair of Locke Lord’s White Collar Defense & Investigations practice group. They dive into recent enforcement actions under the False Claims Act (FCA) at both federal and state levels.

On October 11, Connecticut Attorney General (AG) William Tong announced a $5 million settlement against bankrupt solar installation firm Vision Solar, LLC to resolve an unfair trade practices suit. Hartford Superior Court Judge Daniel Joshua Klau granted the state’s motion for the judgment, which was executed with a trustee for the company and previously approved by a U.S. bankruptcy court. In addition to the $5 million civil penalty, the company also agreed in the stipulation to certain changes in its business practices. However, the changes to its business practices are largely theoretical given that the company is in a liquidation bankruptcy.

On August 7, the U.S. Department of Treasury hosted a virtual briefing to discuss the steps that the Biden-Harris administration is taking to address perceived unfair and deceptive practices in the consumer solar energy industry. Deputy Secretary of Treasury Wally Adeyemo, along with Federal Trade Commission (FTC) Chair Lina Khan and Consumer Financial Protection Bureau (CFPB) Director Rohit Chopra, announced a new interagency consumer solar industry initiative directed at both sales and financing of residential systems. Each made statements about the unique effort to root out anti-competitive and sometimes-fraudulent activity by a handful of “bad actors” who are taking advantage of the burgeoning industry. The presenters also noted that they will be coordinating with state attorneys general (AG) and state financial regulators.

On December 8, the U.S. Small Business Administration (SBA) issued a statement regarding its intent to investigate certain participants in the Paycheck Protection Program (PPP) created by the Coronavirus Aid, Relief, and Economic Security (CARES) Act.[1] This announcement, just a few months after the U.S. Department of Justice (DOJ) announced its first-ever False Claims…

In this episode of Regulatory Oversight, Stephen Piepgrass welcomes Regulatory Investigations, Strategy + Enforcement Partner Amy Williams and Health Sciences Partner Asher Funk to discuss the similarities and differences between the federal False Claims Act and state false claims acts, as well as emerging trends in state false claims act enforcement.